Inflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link
about
Macrophage migration inhibitory factor involvement in breast cancer (Review)Environmental immune disruptors, inflammation and cancer riskRole of macrophage migration inhibitory factor in age-related lung diseaseA multi-targeted approach to suppress tumor-promoting inflammationA Fluorescence Polarization Assay for Binding to Macrophage Migration Inhibitory Factor and Crystal Structures for Complexes of Two Potent InhibitorsInvolvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.Spirotetronate polyketides as leads in drug discovery.HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancerTrichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responsesIn vivo and in vitro anti-inflammatory activity of Cryptostegia grandiflora Roxb. ex R. Br. leaves.Association between macrophage migration inhibitory factor promoter region polymorphism (-173 G/C) and cancer: a meta-analysisMacrophage migration inhibitory factor induces autophagy via reactive oxygen species generationThe modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.MIF antagonist (CPSI-1306) protects against UVB-induced squamous cell carcinomaGlioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner.Design, synthesis, and protein crystallography of biaryltriazoles as potent tautomerase inhibitors of macrophage migration inhibitory factor.Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer.Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression.Plasmodium yoelii macrophage migration inhibitory factor is necessary for efficient liver-stage developmentSteroid receptor coactivator 3 regulates autophagy in breast cancer cells through macrophage migration inhibitory factorInfluence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblastsAn Analysis of MIF Structural Features that Control Functional Activation of CD74.HIF1α deficiency reduces inflammation in a mouse model of proximal colon cancerCorrelation of macrophage migration inhibitory factor gene polymorphism with the risk of early-stage cervical cancer and lymphatic metastasisMIF, secreted by human hepatic sinusoidal endothelial cells, promotes chemotaxis and outgrowth of colorectal cancer in liver prometastasis.microRNA-451 inhibited cell proliferation, migration and invasion through regulation of MIF in renal cell carcinomaAnalysis of protein expression profiles in the thymus of chickens infected with Marek's disease virus.Novel Molecular Insights into Classical and Alternative Activation States of Microglia as Revealed by Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC)-based ProteomicsSecreted and O-GlcNAcylated MIF binds to the human EGF receptor and inhibits its activationTranscriptional Modulation of the ERK1/2 MAPK and NF-κB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer.Spirohexenolide A targets human macrophage migration inhibitory factor (hMIF)Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targetsMacrophage migratory inhibitory factor promotes bladder cancer progression via increasing proliferation and angiogenesis.HIF-α/MIF and NF-κB/IL-6 axes contribute to the recruitment of CD11b+Gr-1+ myeloid cells in hypoxic microenvironment of HNSCC.CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease.Inflammation: what role in pediatric cancer?Beta cell function: the role of macrophage migration inhibitory factor.Novel roles of peroxiredoxins in inflammation, cancer and innate immunity.Macrophage migration inhibitory factor as an incriminating agent in dermatological disorders.Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.
P2860
Q26786136-7FA02BA0-C260-464B-835E-B643E72625D1Q28080870-F314ED04-9C45-49DD-8378-3FBECD638881Q28081711-5176A95E-4399-47E6-A776-1E4094389AAEQ28393278-55679EDA-0849-4E1D-9D25-BD63C48E671EQ28830113-A1B04B4A-E74E-41A3-8041-BC69E509B67EQ30435034-13A23D23-B7EC-40CC-A561-DC684B0AC882Q30872494-373CA8E9-5E50-48CF-B3E3-0729788DB797Q33694931-D6F01846-7A00-4A66-BCB2-D1FDD928DAADQ33730715-75B8B57C-6D07-4A8D-9B45-CAE8D4B5EA89Q33984657-35562DDC-B49D-4588-8E3B-051D4711C4ADQ34100932-FD778A0D-AA35-4F42-8204-CAB17D25E79CQ34282056-2020D985-1955-410C-9973-6164BAB73F6DQ34347558-E7ADD859-707C-474D-AB9B-B2D809BC2AFDQ34825612-7BCBE7BC-5EEC-4829-B75F-BD13D9ACDCC0Q35007567-2C9C01E2-7C60-4F51-AEAA-4457AF6EE65BQ35285019-6E20F07A-8941-48D2-A966-12DB68B2DF5BQ35435019-2CCD96DA-2FF7-4262-A206-9709E7E594F3Q35760817-A7489F0B-4D7A-42D3-8EE0-01CD4D28BBDDQ35867569-7F3044A4-3A99-4547-B25B-6394C70E323EQ36009215-EA18F9FF-2165-489F-AFB8-40320EC35265Q36024387-83191073-D260-48FD-B4B1-0E059A683DF9Q36075317-F652E11D-03B6-4489-AFF9-259F8AA97B9BQ36090805-C769C825-0099-452C-A510-1385BEE92E7BQ36121382-484321D2-B49A-4B47-8902-69ED92A94B82Q36355972-9B6CF773-9635-4973-A28D-2C8A5ED9C728Q36511669-2A36C248-DE63-41DF-936E-8FBFA85CEC79Q36535832-2AC88659-49CB-46CA-8F17-F53F4974C4EBQ36604409-15F5DBA4-4E44-47EC-8C77-8CE4A12F94F2Q36672321-D0DA7484-1601-4C0C-BFB3-08E54AE68881Q36672637-7A19C202-923A-4FA7-875B-6F99D104B808Q36996170-2D8F2231-E1EA-4A88-AA15-285B16792691Q37287944-D193BB7F-C3EB-4F37-AE01-88F53CDDDC45Q37354554-9B479744-6564-4054-993C-2B9379BE238DQ37689607-0B3023B2-BF67-46ED-AFA7-B385BA105FFFQ37826194-E60C8841-0DAA-4E17-95CD-728EDE565D54Q37967667-9EF7A207-A8C3-4611-A57F-5F88B137C0ABQ37990416-DEF2E55C-560E-4E5D-88EA-13CD4D6EF6FEQ37997003-0D396E31-62FA-42A8-B0BA-04548EA0510EQ38110265-94BF151E-24B7-4677-BD71-3EF2B0D1157AQ38455663-5C468499-ABD7-46A1-87E6-47360909EDC3
P2860
Inflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammation and cancer: macro ...... F)--the potential missing link
@en
Inflammation and cancer: macrophage migration inhibitory factor
@nl
type
label
Inflammation and cancer: macro ...... F)--the potential missing link
@en
Inflammation and cancer: macrophage migration inhibitory factor
@nl
prefLabel
Inflammation and cancer: macro ...... F)--the potential missing link
@en
Inflammation and cancer: macrophage migration inhibitory factor
@nl
P2093
P2860
P921
P356
P1476
Inflammation and cancer: macro ...... F)--the potential missing link
@en
P2093
L Mawhinney
S C Donnelly
P275
P2860
P304
P356
10.1093/QJMED/HCQ148
P407
P5008
P577
2010-08-30T00:00:00Z
2010-11-01T00:00:00Z